Ambry Genetics
1 Enterprise
Aliso Viejo, CA 92656
An Innovative Service Laboratory with Clinical Diagnostic and Genomic Services Divisons, Ambry Genetics Serves the Genetics Industry through Friendly, Knowledgeable Client Services and High Quality R&D in a Cutting-Edge Environment
Interview conducted by:
Lynn Fosse, Senior Editor
CEOCFO: Mr. Dunlop, would you tell us the vision when you founded Ambry Genetics and where are you today
Mr. Dunlop: Ambry Genetics is really an innovative company with a unique culture. We started Ambry when the stock market was really high and going the tech bubble. It was really the Glass-Steagall Act bubble. I still remember my father's words, "You may not be ready, but the money is inexpensive now. If you are ever going to start a company, now is the moment." I really thought about it and said, "I am on it." What really contributes to Ambry's unique culture is that it was truly funded by friends and family. In the beginning we only raised five hundred dollars to start the company and all of its operations. To this day everyone thinks that it is kind of crazy but there were no venture capital or institutional investors.
CEOCFO: What is the concept at Ambry Genetics?
Mr. Dunlop: Ambry is an innovative service laboratory with clinical diagnostic and genomic (research) services divisions. I started the company 13 years ago with a thought that we are going to do diagnose and focus on CF and neonatal markets. Several years later, it turned into me trying to keep the innovative spirit alive in different divisions and spokes that have grown from that basic idea. The growth i'm referring to is Ambry being first to introduce next-generation sequencing (NGS) technologies and whole-exome sequencing to the clinical diagnostic space. Today, Ambry us known as the leaders in NGS and we take pride in that. I started the company thinking that I am going to have this cool innovative company; it is going to be fun. It's true. Ambry's general mission is that we use the highest genetic technologies in the worl and apply them to medical problems that are appropriate. The ultimate goal is to find the answer.
Read Full Article Here
Ambry Genetics, a subsidiary of REALM IDx, Inc., translates scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. It is a leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease. Its unparalleled track record of discoveries over 25 years, and growing database that continues to expand in collaboration with academic, corporate and pharmaceutical partners, means Ambry Genetics is first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions.
Media Contact
Mickie Henshall
Chief Marketing Officer
REALM IDx
mhenshall@realmidx.com